A Phase I/II Open Label, Multicenter Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007348/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this Phase I/II study is to evaluate safety, pharmacokinetics, and preliminary
efficacy of the investigational drug PLX3397 in subjects with unresectable or metastatic
KIT-mutated melanoma.
提供机构：
Vivli
创建时间：
2021-08-24
